Lv1
30 积分 2025-08-17 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
1个月前
已完结
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors
1个月前
已完结
Epidermal growth factor receptor mutations in lung cancer
2个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
2个月前
已完结
B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities
3个月前
已完结
JNJ-79032421, a Novel Membrane-restricted Mesothelin-targeting T-cell-engaging Bispecific Antibody for the Treatment of Mesothelin-positive Cancers
3个月前
已完结
Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments
3个月前
已完结
Interleukin 15 and autoimmune disorders: pathophysiology, therapeutic potential, and clinical implications
3个月前
已完结
Potential future biologic therapies for the treatment of vitiligo: focus on phase 2 and 3
3个月前
已完结
皖公网安备34019202002308
